| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Dividendenbekanntmachungen (13.02.2026) | 7.114 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,78 USD 0,6571 EUR A10 NETWORKS INC US0021211018 0,06 USD 0,0505 EUR AGCO CORPORATION US0010841023 0... ► Artikel lesen | |
| Fr | Moderna, Inc.: Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates | 1.336 | ACCESS Newswire | Reports fourth quarter revenue of $0.7 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.11)Reports full-year revenue of $1.9 billion, GAAP net loss of $(2.8) billion and GAAP diluted EPS... ► Artikel lesen | |
| Fr | Medicenna Therapeutics Corp.: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update | 1.059 | GlobeNewswire (Europe) | Medicenna to present updated internal and external data sets related to bizaxofusp (MDNA55) at the 7th Annual Glioblastoma Development Summit to be held in Boston from 17-19 February 2026 Updated... ► Artikel lesen | |
| Fr | Medicenna Therapeutics Corp.: Medicenna Announces Changes to Board Composition | 1.012 | GlobeNewswire (Europe) | TORONTO and HOUSTON, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the... ► Artikel lesen | |
| Fr | HCW Biologics Inc.: HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune | 845 | GlobeNewswire (Europe) | HCW Biologics receiving cash fee and co-founder shares in Trimmunevalued at $7.0 million Trimmune will hold exclusive worldwide license for rights to high potential preclinical molecule created with... ► Artikel lesen | |
| Fr | EQS-News: Amgen: EUROPÄISCHE KOMMISSION GENEHMIGT UPLIZNA VON AMGEN FÜR GENERALISIERTE MYASTHENIA GRAVIS | 725 | EQS Group (DE) | EQS-News: Amgen
/ Schlagwort(e): Sonstiges
EUROPÄISCHE KOMMISSION GENEHMIGT UPLIZNA VON AMGEN FÜR GENERALISIERTE MYASTHENIA GRAVIS
13.02.2026 / 22:55 CET/CEST
Für den... ► Artikel lesen | |
| Fr | BioNTech-Rivale Moderna: Besser als erwartet - ist die Aktie jetzt ein Kauf? | 496 | Der Aktionär | Die US-amerikanische Biotech-Gesellschaft Moderna hat am heutigen Freitag die Zahlen für das abgelaufene vierte Quartal 2025 vorgelegt. Diese lagen deutlich über den Erwartungen. Von den Eckdaten kann... ► Artikel lesen | |
| 07:10 | NurExone Biologic rückt mit validierten Exosomen-Produktionsdaten näher an die Klinik | Small- & Micro Cap Investment | |||
| Fr | Valneva Provides Update on Recommendations for Use of IXCHIQ in the United Kingdom | 462 | GlobeNewswire (Europe) | Lyon (France), February 13, 2026 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that following a review of the benefits and risks of the Company's... ► Artikel lesen | |
| Fr | Xintela AB: Xintela completes clinical study with XSTEM in difficult-to-heal leg ulcers | 416 | GlobeNewswire (Europe) | Xintela (XINT) announces that the company's clinical Phase I/IIa study with XSTEM® in patients with difficult-to-heal venous leg ulcers has been completed with the last follow-up visit for the last... ► Artikel lesen | |
| Fr | dpa-AFX-Überblick: UNTERNEHMEN vom 13.02.2026 - 15.15 Uhr | 407 | dpa-AFX | ROUNDUP: Jenoptik erwartet Rückkehr zu Wachstum - Rechenzentren sollen stützen JENA - Der Technologiekonzern Jenoptik will nach einem Umsatz- und Gewinnrückgang im vergangenen Jahr 2026 wieder auf... ► Artikel lesen | |
| Fr | Exact Sciences Q4 Loss Narrows As Revenues Gain | 322 | AFX News | WASHINGTON (dpa-AFX) - Exact Sciences Corporation (EXAS) on Friday, reported higher revenue for both the fourth quarter and full year ended December 31, 2025, while significantly narrowing its... ► Artikel lesen | |
| Fr | EQS-News: Immunic AG: Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company | 300 | EQS Group (EN) | Issuer: Immunic AG
/ Key word(s): Financing
Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company... ► Artikel lesen | |
| Fr | Moderna Q4 Loss Narrows | 285 | AFX News | WASHINGTON (dpa-AFX) - Moderna, Inc. (MRNA), a biotechnology company, Friday reported narrower loss for the fourth quarter compared to the same period last year.Quarterly loss narrowed to $826... ► Artikel lesen | |
| Fr | Altamira Therapeutics Ltd.: Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray | 257 | ACCESS Newswire | HAMILTON, BM / ACCESS Newswire / February 13, 2026 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company dedicated to developing and supplying nucleic acid delivery technology... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| RECORDATI | 47,620 | 1,30 | +2,73 % | 0,63 | 24.11.2025 | |
| AMGEN | 310,90 | 8,12 | +2,61 % | 2,52 | 13.02.2026 | |
| STRYKER | 307,50 | 2,87 | +0,93 % | 0,88 | 31.03.2026 | |
| BIO-TECHNE | 49,400 | 0,27 | +0,55 % | 0,08 | 13.02.2026 | |
| REGENERON PHARMACEUTICALS | 675,60 | 3,02 | +0,45 % | 0,94 | 20.02.2026 | |
| SARTORIUS STEDIM BIOTECH | 174,65 | 0,69 | +0,40 % | 0,69 | 31.03.2026 | |
| BIOGEN | 166,55 | 0,00 | 0,00 % | |||
| ENZO BIOCHEM | 0,388 | 0,00 | 0,00 % | |||
| MYRIAD GENETICS | 3,900 | 0,00 | 0,00 % | |||
| TRANSGENE | 0,842 | 0,00 | 0,00 % |